Corporate Profile
Insulet Corporation is an innovative medical device company based in Bedford, Massachusetts. It was founded in 2000 with the mission of improving the lives of people with diabetes. Specifically, through its revolutionary OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy.

Studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (MDI); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability1 and improved quality of life2. Despite these benefits, most people still choose MDI therapy largely due to the complexity, cost and inconvenience of conventional pump technology...More >>
PODD (Common Stock)
ExchangeNASDAQ
Price$7.12
Change (%) Stock is Down 0.6 (7.77%)
Volume261,288
Data as of 07/02/09 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Receive E-mail AlertsE-mail Alert Icon
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!
Recent NewsRSS RSS Feeds | More >>
DateTitle 
06/26/09Team Type 1 Takes First Place Finish in Race Across AmericaPrinter Friendly Version
05/28/09Spanish-Speaking OmniPod Customer Support Now Available Around-the-ClockPrinter Friendly Version
05/15/09Juvenile Diabetes Research Foundation to Honor Duane DeSisto of Insulet Corporation and Senator Edward M. Kennedy at 27th Annual Hearts & Heroes GalaPrinter Friendly Version
05/07/09Insulet Reports First Quarter 2009 ResultsPrinter Friendly Version

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.


Printer Friendly Version Printer-friendly version | E-mail this page E-mail this page | RSS RSS Feeds | E-mail Alerts E-mail Alerts